factual

Psychedelic Trials Are Inherently Hard to Blind

It is very hard to keep psychedelic trials blinded because the drugs' effects are so powerful that most participants know they received the active compound—though some guessed wrong in both directions—and this difficulty extends to mental health trials generally, where the endpoint is how patients feel, so a working drug tends to reveal itself.

factualpending

Speaker

Jennifer Mitchell

Evidence Quote

“it's hard to blind mental health treatment trials in general because what you want is for your drug to work and if your drug does people typically know it”

Source

377 - The Future Of Psychedelic Medicine 2— Making Sense with Sam Harris
Created: 6/14/2026, 2:01:41 AM

Your notes

Loading notes...